Back
Arrowhead Pharmaceuticals Stock Price Chart
Sponsored
ARWR
Sponsored
Urgent: The Biggest Gold Bull Market in History Is Here
Click here for urgent details - don't miss out.
Sell
44
ARWR
Arrowhead Pharmaceuticals
Last Price:
20.85
Seasonality Move:
32.21%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!
Don't miss out-click here for urgent details on the #1 gold play of the year!- The current trend is relatively stagnant and ARWR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arrowhead Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.81 | Buy |
20-day SMA: | 19.34 | Buy |
50-day SMA: | 21.52 | Sell |
200-day SMA: | 26.44 | Sell |
8-day EMA: | 19.39 | Buy |
20-day EMA: | 19.61 | Buy |
50-day EMA: | 21.31 | Sell |
200-day EMA: | 25.2 | Sell |
Arrowhead Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 58.18 | Buy |
Chaikin Money Flow: | 1621786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.55 - 20.63) | Buy |
Bollinger Bands (100): | (20.76 - 26.98) | Sell |
Arrowhead Pharmaceuticals Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arrowhead Pharmaceuticals Stock
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 21.10 while ARWR 8-day simple moving average is 18.81, which is a Buy signal.
- The stock price of ARWR is 21.10 while Arrowhead Pharmaceuticals 20-day SMA is 19.34, which makes it a Buy.
- Arrowhead Pharmaceuticals 50-day simple moving average is 21.52 while ARWR share price is 21.10, making it a Sell technically.
- ARWR stock price is 21.10 and Arrowhead Pharmaceuticals 200-day simple moving average is 26.44, creating a Sell signal.
ARWR Technical Analysis vs Fundamental Analysis
Sell
44
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a Sell
The current Arrowhead Pharmaceuticals [ARWR] share price is $21.10. The Score for ARWR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Arrowhead Pharmaceuticals Stock Info
Market Cap:
2.62B
Price in USD:
21.10
Share Volume:
1.68M
Arrowhead Pharmaceuticals 52-Week Range
52-Week High:
39.83
52-Week Low:
17.05
Sell
44
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Arrowhead Pharmaceuticals Share Price Forecast
-
What is the Arrowhead Pharmaceuticals stock price today?
The Arrowhead Pharmaceuticals stock price is 21.10 USD today. -
Will ARWR stock go up or go down?
Arrowhead Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Arrowhead Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arrowhead Pharmaceuticals is overvalued.
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 21.10 while ARWR 8-day exponential moving average is 19.39, which is a Buy signal.
- The stock price of ARWR is 21.10 while Arrowhead Pharmaceuticals 20-day EMA is 19.61, which makes it a Buy.
- Arrowhead Pharmaceuticals 50-day exponential moving average is 21.31 while ARWR share price is 21.10, making it a Sell technically.
- ARWR stock price is 21.10 and Arrowhead Pharmaceuticals 200-day simple moving average is 25.20, creating a Sell signal.
Fundamental Analysis of Arrowhead Pharmaceuticals
Is Arrowhead Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
Technical Analysis of Arrowhead Pharmaceuticals
Should I short Arrowhead Pharmaceuticals stock?
- ARWR Moving Average Covergence Divergence (MACD) indicator is -0.64, suggesting Arrowhead Pharmaceuticals is a Sell
- Arrowhead Pharmaceuticals Relative Strength Index (RSI) is 58.18, which suggest Arrowhead Pharmaceuticals is overbought
- The Bollinger Bands (25) for Arrowhead Pharmaceuticals is (18.55 - 20.63), which suggest Arrowhead Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Arrowhead Pharmaceuticals is (20.76 - 26.98), which suggest Arrowhead Pharmaceuticals is a Sell
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.